Nancy J. Hutson, Director at Clearside Biomedical, Inc. (CLSD), bought 5,000 shares at $3.11 ($16K) on 2021-03-12, disclosed to the SEC on 2021-03-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| CLSD | BUY | 2023-10-04 | $9K | — | Filing → |
| BCRX | SELL | 2023-06-15 | $207K | — | Filing → |
| CLSD | BUY | 2022-11-21 | $40K | — | Filing → |